224 related articles for article (PubMed ID: 22892775)
1. Nephrogenic systemic fibrosis: concepts and perspectives.
Igreja AC; Mesquita Kde C; Cowper SE; Costa IM
An Bras Dermatol; 2012; 87(4):597-607. PubMed ID: 22892775
[TBL] [Abstract][Full Text] [Related]
2. Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.
Bernstein EJ; Schmidt-Lauber C; Kay J
Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):489-503. PubMed ID: 23040363
[TBL] [Abstract][Full Text] [Related]
3. Contemporary applications and limitations of magnetic resonance imaging contrast materials.
Natalin RA; Prince MR; Grossman ME; Silvers D; Landman J
J Urol; 2010 Jan; 183(1):27-33. PubMed ID: 19913804
[TBL] [Abstract][Full Text] [Related]
4. [Nephrogenic systemic fibrosis: a severe complication of use to gadolinium in patients with kidney failure].
Mundim JS; Lorena Sde C; Abensur H; Elias RM; Moysés RM; Castro MC; Romão Júnior JE
Rev Assoc Med Bras (1992); 2009; 55(2):220-5. PubMed ID: 19488662
[TBL] [Abstract][Full Text] [Related]
5. Nephrogenic systemic fibrosis: clinical picture and treatment.
Marckmann P; Skov L
Radiol Clin North Am; 2009 Sep; 47(5):833-40, vi. PubMed ID: 19744598
[TBL] [Abstract][Full Text] [Related]
6. Nephrogenic systemic fibrosis: a review of the new conundrum.
Goenka AH; Das CJ; Sharma R
Natl Med J India; 2009; 22(6):302-6. PubMed ID: 20384019
[TBL] [Abstract][Full Text] [Related]
7. Nephrogenic systemic fibrosis: a concise review for cardiologists.
Cheong BY; Muthupillai R
Tex Heart Inst J; 2010; 37(5):508-15. PubMed ID: 20978560
[TBL] [Abstract][Full Text] [Related]
8. [Nephrogenic fibrosing dermatosis: From clinic to microscopy].
Yoldez H; Ahlem B; Abderrahim E; Faten Z; Soumaya R
Nephrol Ther; 2018 Feb; 14(1):47-49. PubMed ID: 29239786
[TBL] [Abstract][Full Text] [Related]
9. Renal function, nephrogenic systemic fibrosis and other adverse reactions associated with gadolinium-based contrast media.
Canga A; Kislikova M; Martínez-Gálvez M; Arias M; Fraga-Rivas P; Poyatos C; de Francisco AL
Nefrologia; 2014; 34(4):428-38. PubMed ID: 25036056
[TBL] [Abstract][Full Text] [Related]
10. A unique case of nephrogenic systemic fibrosis from gadolinium exposure in a patient with normal eGFR.
Lohani S; Golenbiewski J; Swami A; Halalau A
BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 29025775
[TBL] [Abstract][Full Text] [Related]
11. Gadolinium-associated nephrogenic systemic fibrosis.
Schlaudecker JD; Bernheisel CR
Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
[TBL] [Abstract][Full Text] [Related]
12. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
Kribben A; Witzke O; Hillen U; Barkhausen J; Daul AE; Erbel R
J Am Coll Cardiol; 2009 May; 53(18):1621-8. PubMed ID: 19406336
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
Bertero M; Bainotti S; Comino A; Formica M; Giordano F; Musso L; Palazzini S; Seia Z
Eur J Dermatol; 2009; 19(1):73-4. PubMed ID: 19171533
[No Abstract] [Full Text] [Related]
14. Nephrogenic Systemic Fibrosis Manifesting a Decade After Exposure to Gadolinium.
Larson KN; Gagnon AL; Darling MD; Patterson JW; Cropley TG
JAMA Dermatol; 2015 Oct; 151(10):1117-20. PubMed ID: 26017458
[TBL] [Abstract][Full Text] [Related]
15. Nephrogenic systemic fibrosis: an emerging entity.
Saxena SK; Sharma M; Patel M; Oreopoulos D
Int Urol Nephrol; 2008; 40(3):715-24. PubMed ID: 18418727
[TBL] [Abstract][Full Text] [Related]
16. [Nephrogenic systemic fibrosis: a rare disease with grave consequences].
Kielstein JT; Schiffer M
Internist (Berl); 2010 Jan; 51(1):39-44. PubMed ID: 20033388
[TBL] [Abstract][Full Text] [Related]
17. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
Kay J
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
[TBL] [Abstract][Full Text] [Related]
18. Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
Kitajima K; Maeda T; Watanabe S; Ueno Y; Sugimura K
Int J Urol; 2012 Sep; 19(9):806-11. PubMed ID: 22571387
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium-induced nephrogenic systemic fibrosis.
Hellman RN
Semin Nephrol; 2011 May; 31(3):310-6. PubMed ID: 21784280
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use.
Cheong BYC; Wilson JM; Preventza OA; Muthupillai R
Tex Heart Inst J; 2022 May; 49(3):. PubMed ID: 35612906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
